Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experience
Pérez Ramírez, S., del Monte-Millán, M., López-Tarruella, S., Martínez Jáñez, N., Márquez-Rodas, I., Lobo Samper, F., Izarzugaza Perón, Y., Rubio Terres, C., Rubio Rodríguez, D., García-Sáenz, J. Á., Moreno Antón, F., Zamora Auñón, P., Arroyo Yustos, M., Lara Álvarez, M. Á., Ciruelos Gil, E. M., Manso Sánchez, L., Echarri González, M. J., Guerra Martínez, J. A., Jara Sánchez, C., Bueno Muiño, C., García Adrián, S., Carrión Galindo, J. R., Valentín Maganto, V., Martín, M.
Published in Clinical & translational oncology (01.05.2020)
Published in Clinical & translational oncology (01.05.2020)
Get full text
Journal Article
Management of gastric adenocarcinoma
Khosravi Shahi, P, Díaz Muñoz de la Espada, V M, García Alfonso, P, Encina García, S, Izarzugaza Perón, Y, Arranz Cozar, J L, Hernández Marín, B, Pérez Manga, G
Published in Clinical & translational oncology (01.07.2007)
Published in Clinical & translational oncology (01.07.2007)
Get full text
Journal Article
242P Clinical outcomes in patients (pts) with HR+/HER2− early breast cancer (EBC) by prior systemic treatment (tx): A subgroup analysis of the NATALEE trial
McAndrew, N.P., Chia, S., Puglisi, F., Bardia, A., Peron, Y. Izarzugaza, Schem, C., Xu, B., Le Du, F., Sharma, P., Afenjar, K., Akdere, M., Gonzalez, J.P. Zarate, Chattar, Y., Fasching, P.A.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1056P Efficacy of spartalizumab across multiple cancer types in patients with PD1-high mRNA expressing tumors (SOLTI-1904 ACROPOLI)
Prat, A., Pascual, T., Juan, M., Paz-Ares, L., Felip, E., Garralda, E., Gonzalez-farre, B., Arance Fernandez, A.M., Martin-Liberal, J., López, A., Izarzugaza Peron, Y., Garcia-Corbacho, J., Saura Manich, C., Hierro, C., Sanfeliu Torres, E., Cejalvo, J.M., Salvador, F., Mesia Nin, R., Cervantes, A., Tabernero, J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Adjuvant treatment of operable breast cancer
Khosravi Shahi, P, Izarzugaza Perón, Y, Encinas García, S, Díaz Muñoz de la Espada, V M, Pérez Manga, G
Published in Anales de medicina interna (Madrid, Spain : 1984) (01.01.2008)
Get full text
Published in Anales de medicina interna (Madrid, Spain : 1984) (01.01.2008)
Journal Article
Efficiency of bortezomib and dexamethasone in relapsed multiple myeloma treatment: retrospective study in consecutive cases
Khosravi Shahi, P, Sabin Domínguez, P, Encinas García, S, Izarzugaza Perón, Y, Pérez Manga, G
Published in Anales de medicina interna (Madrid, Spain : 1984) (01.02.2008)
Get full text
Published in Anales de medicina interna (Madrid, Spain : 1984) (01.02.2008)
Journal Article
LBA3 Patritumab deruxtecan (HER3-DXd) in early-stage HR+/HER2- breast cancer: Final results of the SOLTI TOT-HER3 window of opportunity trial
Prat, A., Falato, C., Pare Brunet, L., Martinez Saez, O., Cejalvo Andujar, J.M., Margeli Vila, M., Tolosa, P., Salvador Bofill, F.J., Cruz Jurado, J., Gonzalez-Farre, B., Sanfeliu Torres, E., Ciruelos, E.M., Espinosa-Bravo, M., Izarzugaza Peron, Y., Pernas Simon, S., Esker, S., Fan, P-D., Ferrero Cafiero, J.M., Pascual, T., Oliveira, M.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
354TiP Unraveling trastuzumab emtansine resistance in HER2-positive advanced breast cancer: GEICAM KATIA study
Todo, F. Rojo, Stradella, A., García-Sáenz, J.A., De Las Heras, B. Bermejo, Romero, J.L. Alfonso, Barnadas, A., Peron, Y. Izarzugaza, Alba, E., López-Tarruella, S., Henao-Carrasco, F., Carrasco, E., Caballero, R., Del Campo, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
265TiP SOLTI-2201 ACROSS-TROP2 trial: A phase II study to identify predictive biomarkers of sacituzumab govitecan benefit and to understand resistance mechanisms in HR+/HER2- advanced or metastatic breast cancer
Ciruelos, E.M., Pascual, T., Vazquez, R. Villanueva, Cejalvo, J.M., Parraga, K. Amillano, Bofill, F.J. Salvador, López-Barajas, I. Blancas, Diez, A. Ferrando, Peron, Y. Izarzugaza, Puy, M. Borrell, Fernandez-Martinez, A., Javierre, G. Villacampa, Ferrero-Cafiero, J.M., Dias, M. Paes, Salvador, F., Oliveira, M.
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
Distribution of genomically defined recurrence risk in luminal A and B breast tumors defined by inmunohistochemistry: A retrospective study in Spanish population
Perez Ramirez, S., del Monte-Millán, M., López-Tarruella, S., Márquez-Rodas, I., Jerez, Y., Lobo Samper, F., Izarzugaza Peron, Y., Martínez Jañez, N., García-Saenz, J.A., Moreno Antón, F., Zamora Auñón, P., Arroyo Yustos, M., Lara Álvarez, M.Á., Ciruelos Gil, E.M., Manso Sánchez, L., Echarri González, M.J., Guerra Martínez, J.A., Jara Sánchez, C., Valentín Maganto, V., Martin Jimenez, M.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Low pathologic complete response (pCR) rate to neoadjuvant chemotherapy in invasive lobular carcinoma of breast: Analysis of subgroup of four phase II trials
Khosravi-Shahi, P., Izarzugaza Peron, Y., Perez-Manga, G.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Phase II study of neoadjuvant treatment with docetaxel, capecitabine, and trastuzumab in HER-2-positive locally advanced or inflammatory breast cancer: TXH trial
Perez Manga, G., Khosravi-Shahi, P., Izarzugaza Peron, Y., Soria Lovelle, A., Gonzalez del Val, R., Palomero Plaza, M., Riesco Martinez, M., Jerez Gilarranz, Y., Adeva Alfonso, J., Alonso, A.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Abstract P6-07-21: High reduction of circulating tumour cells in HER2-negative locally advanced or metastatic breast cancer (LAMBC) patients treated with eribulin as third line chemotherapy (ONSITE study)
Manso Sánchez, L, Moreno Antón, F, Izarzugaza Perón, Y, Delgado Mingorance, I, Borrega García, P, Echarri González, MJ, Martínez Jáñez, N, López González, A, Olier Garate, C, Ballesteros García, A, Chacón López-Muñiz, I, Ciruelos Gil, EM, García Sáenz, JA, Paz-Ares Rodríguez, L
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Single arm, multicentre, non-randomized open-label trial to evaluate the safety of eribulin in third line chemotherapy in patients with HER2-negative metastatic or locally advanced breast cancer previously treated with anthracyclines and taxanes: Onsite study (ONCOSUR 2012-02)
Sánchez, L.M. Manso, Antón, F. Moreno, Perón, Y. Izarzugaza, De Mingorance, J. Ilgado, Borrega, P., González, M.J. Echarri, Martínez, N., González, A. López, Olier, C., García, A. Ballesteros, Chacón, I., Ciruelos, E., García-Sáenz, J.A., Paz-Ares, L.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Efectividad de bortezomib y dexametasona en el tratamiento de mieloma múltiple refractario: estudio retrospectivo de una serie de casos consecutivos
Khosravi Shahi, P., Sabin Domínguez, P., Encinas García, S., Izarzugaza Perón, Y., Pérez Manga, G.
Published in Anales de medicina interna (Madrid, Spain : 1984) (01.02.2008)
Published in Anales de medicina interna (Madrid, Spain : 1984) (01.02.2008)
Get full text
Journal Article